Literature DB >> 10996923

[Advances in neonatal neurology: 1950-2000].

M R Koenigsberger1.   

Abstract

INTRODUCTION: There have been innumerable advances in medicine and its specialties in the last half century. Neonatal intensive care did not really begin until the 1960's, when adequate mechanical ventilation for newborns became generally available. DEVELOPMENT AND
CONCLUSIONS: With the increased survival of very small prematures, even with a smaller individual morbidity, a larger total number of survivors is graduating these units. Will they be able to function in this increasingly more complicated world? Organizational, Diagnostic, and Therapeutic advances in Neonatology and Neonatal Neurology are reviewed. Then, advances in some of those neonatal entities that threaten the CNS are briefly reviewed. Congenital anomalies, metabolic disease, infection, intraventricular hemorrhage, hydrocephalus, periventricular leukomalacia, are touched upon. Finally, the entity of hypoxi-ischemic encephalopathy is reviewed, emphasizing that its morbidity has changed little through the years, and describing a new hypothermic approach to its management currently under way in a global cooperative study.

Entities:  

Mesh:

Year:  2000        PMID: 10996923

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  7 in total

1.  G-CSF attenuates neuroinflammation and stabilizes the blood-brain barrier via the PI3K/Akt/GSK-3β signaling pathway following neonatal hypoxia-ischemia in rats.

Authors:  Li Li; Devin W McBride; Desislava Doycheva; Brandon J Dixon; Paul R Krafft; John H Zhang; Jiping Tang
Journal:  Exp Neurol       Date:  2015-01-10       Impact factor: 5.330

2.  MicroRNA-210 Downregulates ISCU and Induces Mitochondrial Dysfunction and Neuronal Death in Neonatal Hypoxic-Ischemic Brain Injury.

Authors:  Qingyi Ma; Chiranjib Dasgupta; Yong Li; Lei Huang; Lubo Zhang
Journal:  Mol Neurobiol       Date:  2019-01-17       Impact factor: 5.590

3.  C-type natriuretic peptide functions as an innate neuroprotectant in neonatal hypoxic-ischemic brain injury in mouse via natriuretic peptide receptor 2.

Authors:  Qingyi Ma; Lubo Zhang
Journal:  Exp Neurol       Date:  2018-03-05       Impact factor: 5.330

4.  G-CSF ameliorates neuronal apoptosis through GSK-3β inhibition in neonatal hypoxia-ischemia in rats.

Authors:  Li Li; Damon Klebe; Desislava Doycheva; Devin W McBride; Paul R Krafft; Jerry Flores; Changman Zhou; John H Zhang; Jiping Tang
Journal:  Exp Neurol       Date:  2014-10-18       Impact factor: 5.330

5.  Anti-neutrophil antibody enhances the neuroprotective effects of G-CSF by decreasing number of neutrophils in hypoxic ischemic neonatal rat model.

Authors:  Desislava M Doycheva; Tiffany Hadley; Li Li; Richard L Applegate; John H Zhang; Jiping Tang
Journal:  Neurobiol Dis       Date:  2014-05-27       Impact factor: 5.996

6.  MicroRNA-210 downregulates TET2 and contributes to inflammatory response in neonatal hypoxic-ischemic brain injury.

Authors:  Qingyi Ma; Chiranjib Dasgupta; Guofang Shen; Yong Li; Lubo Zhang
Journal:  J Neuroinflammation       Date:  2021-01-05       Impact factor: 8.322

7.  MicroRNA-210 Suppresses Junction Proteins and Disrupts Blood-Brain Barrier Integrity in Neonatal Rat Hypoxic-Ischemic Brain Injury.

Authors:  Qingyi Ma; Chiranjib Dasgupta; Yong Li; Lei Huang; Lubo Zhang
Journal:  Int J Mol Sci       Date:  2017-06-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.